Rosenblatt analyst Mike Genovese maintains Calix (NYSE:CALX) with a Buy and raises the price target from $47 to $57.
Rosenblatt Maintains Buy on Calix, Raises Price Target to $57-Report Released on 2nd January 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.